Why Merger Policy Matters
August 23, 2022 — On the heels of a historic post-pandemic merger wave, and a recent joint Federal Trade Commission and Department of Justice merger guideline rewriting initiative, the American Economic Liberties Project released “Why Merger Policy Matters,” highlighting why the movement underway to rethink merger policy is key to leveling the playing field for businesses, consumers, and working people.
Morgan’s Monopoly Digest – August 2022
August 10, 2022 — Economic Liberties' Director of Policy & Advocacy Morgan Harper launched a monthly newsletter to catalogue the latest with the “antitrust agencies,” the Federal Trade Commission (FTC) and the Department of Justice (DOJ), Antitrust Division, as well as cover the work of other federal agencies that regulate competition policy.
Star-Ledger: Camden group hopes to expose the truth about corporate subsidies | Opinion
July 29, 2022 — In NJ Star-Ledger, Economic Liberties' Director of State & Local Policy Pat Garofalo details how a New Jersey town fought back against a harmful corporate subsidy agreement.
Ban Secret Deals: How Secret Corporate Subsidy Deals Harm Communities, and What to Do About It
July 28, 2022 — A joint report from the American Economic Liberties Project and Fight Corporate Monopolies, "Ban Secret Deals: How Secret Corporate Subsidy Deals Harm Communities, and What to Do About It," details the harmful nature of secretive “economic development” deals and provides local communities with tools to combat them.
USA Today: Don’t let the airlines fool you. Regulate their cancellations and high fares.
July 21, 2022 — In USA Today, Economic Liberties’ Senior Fellow for Aviation & Travel Bill McGee lays out the causes of the current airline and travel crisis, highlighting Secretary Buttigieg’s inadequate response and arguing for rolling back federal preemption, which currently prevents state attorneys general among others from holding the airlines accountable.
The Pharmacy Benefit Mafia: The Secret Health Care Monopolies Jacking Up Drug Prices and Abusing Patients and Pharmacists
June 22, 2022 — Designed to catalogue the ways PBMs wield their power to exploit patients, pharmacists, doctors and our government, "The Pharmacy Benefit Mafia" details PBMs’ abusive business practices, their history of skirting regulation, and how the FTC’s recent efforts can put power back into the hands of patients and pharmacists.